<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="id">
	<id>https://wiki.unissula.ac.id/index.php?action=history&amp;feed=atom&amp;title=Fibrinopeptida</id>
	<title>Fibrinopeptida - Riwayat revisi</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.unissula.ac.id/index.php?action=history&amp;feed=atom&amp;title=Fibrinopeptida"/>
	<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Fibrinopeptida&amp;action=history"/>
	<updated>2026-09-16T11:39:12Z</updated>
	<subtitle>Riwayat revisi halaman ini di wiki</subtitle>
	<generator>MediaWiki 1.46.0</generator>
	<entry>
		<id>https://wiki.unissula.ac.id/index.php?title=Fibrinopeptida&amp;diff=27494&amp;oldid=prev</id>
		<title>Maintenance script: Presentation V4: sitasi, referensi, Math, Wikimedia Commons, dan atribusi</title>
		<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Fibrinopeptida&amp;diff=27494&amp;oldid=prev"/>
		<updated>2026-08-29T18:07:45Z</updated>

		<summary type="html">&lt;p&gt;Presentation V4: sitasi, referensi, Math, Wikimedia Commons, dan atribusi&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;id&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Revisi sebelumnya&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisi per 29 Agustus 2026 18.07&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Baris 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Baris 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;Fibrinopeptida, fibrinopeptida A&#039;&#039;&#039; (disingkat &#039;&#039;&#039;FpA&#039;&#039;&#039;) dan &#039;&#039;&#039;fibrinopeptida B&#039;&#039;&#039; (disingkat &#039;&#039;&#039;FpB&#039;&#039;&#039;), adalah &lt;/del&gt;[[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;peptida]] yang terletak di wilayah tengah [[glikoprotein]] ber[[serat]] [[fibrinogen]] (faktor I) dan dibelah oleh [[enzim]] [[trombin]] (faktor IIa) untuk mengubah fibrinogen menjadi [[monomer]] [[fibrin]] (faktor IA) yang [[ikatan kovalen&lt;/del&gt;|&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;terikat secara kovalen]]. FpA [N-terminus&lt;/del&gt;|&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;N-terminal]] dibelah dari rantai Aα fibrinogen dan FpB dari rantai Bβ fibrinogen, dengan FpA dilepaskan sebelum FpB. Setelah terbentuk, monomer fibrin diubah menjadi [[polimer]] fibrin yang terikat silang oleh aksi faktor XIII yang diaktifkan trombin (faktor penstabil fibrin), dan polimer fibrin ini membentuk &quot;tulang punggung&quot; [[trombus&lt;/del&gt;]] &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(bekuan darah). Oleh karena itu, fibrinopeptida merupakan penanda sensitif fibrinogenesis (pembentukan fibrin), aktivitas [[trombin]], dan [[koagulasi]].&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;File:Fibrinopeptide_A.svg|thumb|right&lt;/ins&gt;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;280px&lt;/ins&gt;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Fibrinopeptide A&lt;/ins&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;FpA adalah peptida &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;16 &lt;/del&gt;[[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;asam amino&lt;/del&gt;]].[[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Waktu paruh&lt;/del&gt;]] &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;FpA sangat singkat&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;yaitu sekitar &lt;/del&gt;3 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;hingga 5 menit&lt;/del&gt;. Oleh karena itu, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kadar FpA memberikan ukuran aktivasi &lt;/del&gt;koagulasi &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;yang relatif sementara&lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;Fibrinopeptida, fibrinopeptida A&#039;&#039;&#039; (disingkat &#039;&#039;&#039;&lt;/ins&gt;FpA&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;) dan &#039;&#039;&#039;fibrinopeptida B&#039;&#039;&#039; (disingkat &#039;&#039;&#039;FpB&#039;&#039;&#039;), &lt;/ins&gt;adalah &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/ins&gt;peptida&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] yang terletak di wilayah tengah [[glikoprotein]] ber[[serat]] &lt;/ins&gt;[[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;fibrinogen]] (faktor I) dan dibelah oleh [[enzim]] [[trombin]] (faktor IIa) untuk mengubah fibrinogen menjadi [[monomer]] [[fibrin]] (faktor IA) yang [[ikatan kovalen|terikat secara kovalen]].&amp;lt;ref&amp;gt;&#039;&#039;Fibrinogen and fibrin&#039;&#039;. &#039;&#039;Adv Protein Chem&#039;&#039;. 2005. Vol. 70. hlm. 247–99. doi:10.1016/S0065-3233(05)70008-5. ISBN 9780120342709.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;Comparative aspects of blood coagulation&#039;&#039;. &#039;&#039;Vet J&#039;&#039;. November 2004. Vol. 168 (3). hlm. 238–51. doi:10.1016/j.tvjl.2003.09.013.&amp;lt;/ref&amp;gt; FpA [N-terminus|N-terminal&lt;/ins&gt;]] &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dibelah dari rantai Aα fibrinogen dan FpB dari rantai Bβ fibrinogen, dengan FpA dilepaskan sebelum FpB.&amp;lt;ref&amp;gt;&#039;&#039;Determinants of fibrin formation, structure, and function&#039;&#039;. &#039;&#039;Curr Opin Hematol&#039;&#039;. September 2012. Vol. 19 (5). hlm. 349–56. doi:10.1097/MOH.0b013e32835673c2.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Máiread N O&#039;Riordan. &#039;&#039;Haemostasis in normal and abnormal pregnancy&#039;&#039;. &#039;&#039;Best Practice &amp;amp; Research Clinical Obstetrics &amp;amp; Gynaecology&#039;&#039;. June 2003. Vol. 17 (3). hlm. 385–396&lt;/ins&gt;. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doi:10.1016/S1521-6934(03)00019-1.&amp;lt;/ref&amp;gt; Setelah terbentuk, monomer fibrin diubah menjadi &lt;/ins&gt;[[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;polimer&lt;/ins&gt;]] &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;fibrin yang terikat silang oleh aksi faktor XIII yang diaktifkan trombin (faktor penstabil fibrin)&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dan polimer fibrin ini membentuk &quot;tulang punggung&quot; [[trombus]] (bekuan darah).&amp;lt;ref&amp;gt;&#039;&#039;Comparative aspects of blood coagulation&#039;&#039;. &#039;&#039;Vet J&#039;&#039;. November 2004. Vol. 168 (&lt;/ins&gt;3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;). hlm. 238–51. doi:10.1016/j.tvjl.2003.09.013&lt;/ins&gt;.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt; &lt;/ins&gt;Oleh karena itu, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;fibrinopeptida merupakan penanda sensitif fibrinogenesis (pembentukan fibrin), aktivitas [[trombin]], dan [[&lt;/ins&gt;koagulasi&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]].&amp;lt;ref&amp;gt;&#039;&#039;Mechanisms, markers and management of coagulation activation&#039;&#039;. &#039;&#039;Br Med Bull&#039;&#039;. October 1994. Vol. 50 (4). hlm. 851–70. doi:10.1093/oxfordjournals.bmb.a072930.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Vincent Marks. [https://books.google.com/books?id=_VjrCAAAQBAJ&amp;amp;pg=PA443 Differential Diagnosis by Laboratory Medicine: A Quick Reference for Physicians]. Springer Science &amp;amp; Business Media. 6 December 2012. hlm. 443–. ISBN 978-3-642-55600-5.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis&#039;&#039;. &#039;&#039;Expert Rev Clin Pharmacol&#039;&#039;. October 2017. Vol. 10 (10). hlm. 1129–1144. doi:10.1080/17512433.2017.1356718.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know&#039;&#039;. &#039;&#039;J Thromb Thrombolysis&#039;&#039;. 1995. Vol. 2 (2). hlm. 85–92. doi:10.1007/BF01064374&lt;/ins&gt;.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Kadar &lt;/del&gt;FpA &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;meningkat seiring bertambahnya usia. Kadar FpA juga secara bertahap meningkat selama &lt;/del&gt;[[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kehamilan&lt;/del&gt;]]. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Demikian pula, kadar FpA dilaporkan meningkat dengan terapi estrogen termasuk dengan &lt;/del&gt;[[&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pil kontrasepsi oral gabungan]] dan [[terapi penggantian hormon|terapi hormon menopause&lt;/del&gt;]], &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;meskipun penelitian tentang &lt;/del&gt;kadar FpA &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dengan terapi ini tampaknya &lt;/del&gt;relatif &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;terbatas&lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;FpA &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adalah peptida 16 &lt;/ins&gt;[[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;asam amino&lt;/ins&gt;]].[[&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Waktu paruh&lt;/ins&gt;]] &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;FpA sangat singkat, yaitu sekitar 3 hingga 5 menit.&amp;lt;ref&amp;gt;&#039;&#039;Mechanisms, markers and management of coagulation activation&#039;&#039;. &#039;&#039;Br Med Bull&#039;&#039;. October 1994. Vol. 50 (4). hlm. 851–70. doi:10.1093/oxfordjournals.bmb.a072930.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know&#039;&#039;. &#039;&#039;J Thromb Thrombolysis&#039;&#039;. 1995. Vol. 2 (2). hlm. 85–92. doi:10.1007/BF01064374.&amp;lt;/ref&amp;gt; Oleh karena itu&lt;/ins&gt;, kadar FpA &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;memberikan ukuran aktivasi koagulasi yang &lt;/ins&gt;relatif &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;sementara.&amp;lt;ref&amp;gt;&#039;&#039;Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know&#039;&#039;. &#039;&#039;J Thromb Thrombolysis&#039;&#039;. 1995. Vol. 2 (2). hlm. 85–92. doi:10.1007/BF01064374&lt;/ins&gt;.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;==Referensi==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Kadar FpA meningkat seiring bertambahnya usia.&amp;lt;ref&amp;gt;&#039;&#039;Mechanisms, markers and management of coagulation activation&#039;&#039;. &#039;&#039;Br Med Bull&#039;&#039;. October 1994. Vol. 50 (4). hlm. 851–70. doi:10.1093/oxfordjournals.bmb.a072930.&amp;lt;/ref&amp;gt; Kadar FpA juga secara bertahap meningkat selama [[kehamilan]].&amp;lt;ref&amp;gt;&#039;&#039;Hemostasis during normal pregnancy and puerperium&#039;&#039;. &#039;&#039;Semin Thromb Hemost&#039;&#039;. April 2003. Vol. 29 (2). hlm. 125–30. doi:10.1055/s-2003-38897.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Ekaterina Koltsova. &#039;&#039;Classic and Global Hemostasis Testing in Pregnancy and during Pregnancy Complications&#039;&#039;. &#039;&#039;Seminars in Thrombosis and Hemostasis&#039;&#039;. 21 September 2016. Vol. 42 (7). hlm. 696–716. doi:10.1055/s-0036-1592303.&amp;lt;/ref&amp;gt; Demikian pula, kadar FpA dilaporkan meningkat dengan terapi estrogen termasuk dengan [[pil kontrasepsi oral gabungan]] dan [[terapi penggantian hormon|terapi hormon menopause]], meskipun penelitian tentang kadar FpA dengan terapi ini tampaknya relatif terbatas.&amp;lt;ref&amp;gt;&#039;&#039;Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk&#039;&#039;. &#039;&#039;Semin Thromb Hemost&#039;&#039;. November 2020. Vol. 46 (8). hlm. 872–886. doi:10.1055/s-0040-1714140.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;[https://www.hal.inserm.fr/inserm-01148743/file/Canonico_Menopause_2014_2.pdf Hormone therapy and hemostasis among postmenopausal women: a review]. &#039;&#039;Menopause&#039;&#039;. July 2014. Vol. 21 (7). hlm. 753–62. doi:10.1097/GME.0000000000000296.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;The role of estrogen in cardiovascular disease&#039;&#039;. &#039;&#039;J Surg Res&#039;&#039;. December 2003. Vol. 115 (2). hlm. 325–44. doi:10.1016/s0022-4804(03)00215-4.&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&#039;&#039;Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis&#039;&#039;. &#039;&#039;Expert Rev Clin Pharmacol&#039;&#039;. October 2017. Vol. 10 (10). hlm. 1129–1144. doi:10.1080/17512433.2017.1356718.&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Referensi ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;references /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Sumber dan atribusi ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Sumber &lt;/del&gt;dan &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;atribusi ==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title&lt;/ins&gt;=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Fibrinopeptida&amp;amp;oldid&lt;/ins&gt;=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;28803872 Wikipedia bahasa Indonesia], revisi 28803872 (2026-01-12T05:47:29Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Gambar pada artikel ini bersumber dari Wikimedia Commons &lt;/ins&gt;dan &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mengikuti ketentuan lisensi masing-masing berkas. Mohon gunakan konten dan media secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title=Fibrinopeptida&amp;amp;oldid=28803872 Wikipedia bahasa Indonesia], revisi 28803872 (2026&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;01&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;12T05:47:29Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;BerbagiSerupa (CC BY&lt;/del&gt;-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;!&lt;/ins&gt;-- &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;WIKI_UNISSULA_PRESENTATION_V4 &lt;/ins&gt;--&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
	<entry>
		<id>https://wiki.unissula.ac.id/index.php?title=Fibrinopeptida&amp;diff=27095&amp;oldid=prev</id>
		<title>Maintenance script: Impor teks terkontrol dari Wikipedia bahasa Indonesia; revisi 28803872; atribusi sumber disertakan.</title>
		<link rel="alternate" type="text/html" href="https://wiki.unissula.ac.id/index.php?title=Fibrinopeptida&amp;diff=27095&amp;oldid=prev"/>
		<updated>2026-08-29T17:36:56Z</updated>

		<summary type="html">&lt;p&gt;Impor teks terkontrol dari Wikipedia bahasa Indonesia; revisi 28803872; atribusi sumber disertakan.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Halaman baru&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Fibrinopeptida, fibrinopeptida A&amp;#039;&amp;#039;&amp;#039; (disingkat &amp;#039;&amp;#039;&amp;#039;FpA&amp;#039;&amp;#039;&amp;#039;) dan &amp;#039;&amp;#039;&amp;#039;fibrinopeptida B&amp;#039;&amp;#039;&amp;#039; (disingkat &amp;#039;&amp;#039;&amp;#039;FpB&amp;#039;&amp;#039;&amp;#039;), adalah [[peptida]] yang terletak di wilayah tengah [[glikoprotein]] ber[[serat]] [[fibrinogen]] (faktor I) dan dibelah oleh [[enzim]] [[trombin]] (faktor IIa) untuk mengubah fibrinogen menjadi [[monomer]] [[fibrin]] (faktor IA) yang [[ikatan kovalen|terikat secara kovalen]]. FpA [N-terminus|N-terminal]] dibelah dari rantai Aα fibrinogen dan FpB dari rantai Bβ fibrinogen, dengan FpA dilepaskan sebelum FpB. Setelah terbentuk, monomer fibrin diubah menjadi [[polimer]] fibrin yang terikat silang oleh aksi faktor XIII yang diaktifkan trombin (faktor penstabil fibrin), dan polimer fibrin ini membentuk &amp;quot;tulang punggung&amp;quot; [[trombus]] (bekuan darah). Oleh karena itu, fibrinopeptida merupakan penanda sensitif fibrinogenesis (pembentukan fibrin), aktivitas [[trombin]], dan [[koagulasi]].&lt;br /&gt;
&lt;br /&gt;
FpA adalah peptida 16 [[asam amino]].[[Waktu paruh]] FpA sangat singkat, yaitu sekitar 3 hingga 5 menit. Oleh karena itu, kadar FpA memberikan ukuran aktivasi koagulasi yang relatif sementara.&lt;br /&gt;
&lt;br /&gt;
Kadar FpA meningkat seiring bertambahnya usia. Kadar FpA juga secara bertahap meningkat selama [[kehamilan]]. Demikian pula, kadar FpA dilaporkan meningkat dengan terapi estrogen termasuk dengan [[pil kontrasepsi oral gabungan]] dan [[terapi penggantian hormon|terapi hormon menopause]], meskipun penelitian tentang kadar FpA dengan terapi ini tampaknya relatif terbatas.&lt;br /&gt;
&lt;br /&gt;
==Referensi==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Sumber dan atribusi ==&lt;br /&gt;
&lt;br /&gt;
Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title=Fibrinopeptida&amp;amp;oldid=28803872 Wikipedia bahasa Indonesia], revisi 28803872 (2026-01-12T05:47:29Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>